Jonathan G. Sham

1.1k total citations
31 papers, 865 citations indexed

About

Jonathan G. Sham is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Jonathan G. Sham has authored 31 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Jonathan G. Sham's work include Pancreatic and Hepatic Oncology Research (12 papers), Neuroendocrine Tumor Research Advances (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jonathan G. Sham is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Neuroendocrine Tumor Research Advances (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jonathan G. Sham collaborates with scholars based in United States, Canada and Chile. Jonathan G. Sham's co-authors include Miqin Zhang, Forrest M. Kievit, James O. Park, Raymond S. Yeung, Venu G. Pillarisetty, Stephen J. Florczyk, Soumen Jana, Kui Wang, David L. Wood and Zachary R. Stephen and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Jonathan G. Sham

27 papers receiving 857 citations

Peers

Jonathan G. Sham

ONCOL

BIOMA

HEPAT

G. Kesava Reddy United States

Carola Heneweer Germany

Dennis Doleschel Germany

Lotfi Abou‐Elkacem United States

Charlotte E.S. Hoogstins Netherlands

Awalpreet S. Chadha United States

Kosuke Ogawa Japan

Kirk Fowers United States

Xiaoli Wei China

Masako Oka Japan

G. Kesava Reddy United States

Jonathan G. Sham

234 ×0.7

ONCOL

116 ×0.5

254 ×1.3

85 ×0.5

BIOMA

110 ×0.7

HEPAT

Citations per year, relative to Jonathan G. Sham Jonathan G. Sham (= 1×) peers G. Kesava Reddy

Countries citing papers authored by Jonathan G. Sham

Since Specialization

Citations

This map shows the geographic impact of Jonathan G. Sham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan G. Sham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan G. Sham more than expected).

Fields of papers citing papers by Jonathan G. Sham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan G. Sham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan G. Sham. The network helps show where Jonathan G. Sham may publish in the future.

Co-authorship network of co-authors of Jonathan G. Sham

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan G. Sham. A scholar is included among the top collaborators of Jonathan G. Sham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan G. Sham. Jonathan G. Sham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hernández, Alexandra, Nina M. Clark, Charles Y. Liu, et al.. (2025). Financial Hardship After Surgical Procedures. JAMA Surgery. 161(1). 59–59.

Pillarisetty, Venu G., et al.. (2025). Somatostatin Analogs for Preventing Postoperative Pancreatic Fistula: Past Evidence Reveals New Opportunities. Annals of Surgical Oncology. 32(10). 7382–7392.

Safyan, Rachael A., Smith Apisarnthanarax, Jonathan G. Sham, et al.. (2025). Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma. Advances in Radiation Oncology. 10(4). 101742–101742.

Sham, Jonathan G., et al.. (2024). Prophylactic somatostatin analogs for postoperative pancreatic fistulas: a cross-sectional survey of AHPBA surgeons. HPB. 26(10). 1229–1236. 1 indexed citations

Park, James O., et al.. (2024). Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT framework. Journal of Surgical Oncology. 130(3). 476–484. 3 indexed citations

Pillarisetty, Venu G., Arezou Abbasi, James O. Park, & Jonathan G. Sham. (2022). A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula. HPB. 24(11). 2029–2034. 10 indexed citations

Abbasi, Arezou, et al.. (2022). Lanreotide for the Prevention of Postoperative Pancreatic Fistula: Phase Ii Clinical Trial Results. HPB. 24. S387–S387. 1 indexed citations

Clark, Nina M., Emma A. Roberts, Catherine R. Fedorenko, et al.. (2022). Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers. Annals of Surgical Oncology. 30(3). 1312–1326. 8 indexed citations

Labadie, Kevin P., Sara K. Daniel, Yongwoo David Seo, et al.. (2021). IWATE criteria are associated with perioperative outcomes in robotic hepatectomy: a retrospective review of 225 resections. Surgical Endoscopy. 36(2). 889–895. 24 indexed citations

10.

Labadie, Kevin P., Donald K. Hamlin, Aimee L. Kenoyer, et al.. (2021). Glypican-3–Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma. Journal of Nuclear Medicine. 63(7). 1033–1038. 20 indexed citations

11.

Labadie, Kevin P., Andrew D. Ludwig, Donald K. Hamlin, et al.. (2021). Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma. Scientific Reports. 11(1). 3731–3731. 14 indexed citations

12.

Sham, Jonathan G., et al.. (2020). Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody. Annals of Surgical Oncology. 27(11). 4070–4072. 1 indexed citations

13.

Barry, Aisling, Smith Apisarnthanarax, Grainne M. O’Kane, et al.. (2020). Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. The Lancet. Gastroenterology & hepatology. 5(8). 765–775. 27 indexed citations

14.

Chouliaras, Konstantinos, Naeem A. Newman, Katrina Swett, et al.. (2018). Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. Journal of Surgical Oncology. 118(3). 416–421. 15 indexed citations

15.

Karunasena, Enusha, Jonathan G. Sham, K. Wyatt McMahon, & Nita Ahuja. (2018). Genomics of Peritoneal Malignancies. Surgical Oncology Clinics of North America. 27(3). 463–475. 10 indexed citations

16.

Sham, Jonathan G., Morgan K. Richards, Yongwoo David Seo, et al.. (2016). Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?. Journal of Robotic Surgery. 10(4). 307–313. 66 indexed citations

17.

Kievit, Forrest M., Zachary R. Stephen, Kui Wang, et al.. (2015). Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ‐irradiation. Molecular Oncology. 9(6). 1071–1080. 53 indexed citations

18.

Simianu, Vlad V., Jonathan G. Sham, Andrew S. Wright, et al.. (2015). A Large Animal Survival Model to Evaluate Bariatric Surgery Mechanisms. Surgical Science. 6(8). 337–345. 3 indexed citations

19.

Shibuya, Kendall C., Vikas Goel, Wei Xiong, et al.. (2014). Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment. PLoS ONE. 9(5). e96565–e96565. 99 indexed citations

20.

Florczyk, Stephen J., Kui Wang, Soumen Jana, et al.. (2013). Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM. Biomaterials. 34(38). 10143–10150. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact